WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) shares traded up 4.8% on Tuesday . The stock traded as high as $12.5850 and last traded at $12.5850. 2,049 shares were traded during trading, a decline of 97% from the average session volume of 70,663 shares. The stock had previously closed at $12.01.
Analysts Set New Price Targets
Separately, Zacks Research raised shares of WuXi Biologics (Cayman) to a “hold” rating in a research report on Friday, August 28th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat.com, WuXi Biologics (Cayman) has an average rating of “Hold”.
Check Out Our Latest Stock Analysis on WXXWY
WuXi Biologics (Cayman) Stock Down 0.6%
About WuXi Biologics (Cayman)
WuXi Biologics (Cayman) is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company provides integrated services to pharmaceutical and biotechnology customers across the development cycle, from early-stage discovery and preclinical research through clinical development, regulatory support and commercial manufacturing.
Its capabilities include the development and production of monoclonal antibodies, recombinant proteins, vaccines, antibody-drug conjugates and other biologic modalities.
Read More
- Five stocks we like better than WuXi Biologics (Cayman)
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
- Cashing in on the Qubit: NVIDIA Takes the Quantum Leap
- Ready to Rumble: Anthropic Rings the AI Bell
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
